InterMune has not publicly hinted at what it may be this is just my speculation. The closest (I heard) was in response to a question at a conference once Dan Welch was asked about what he thought the HCV market place would look like and in addition to mentioning the PI he said there are also other targets that we and others are working on including Polymerase and Helicase. That is why I thought it could be one of these.
Market Data 
Markets 
AI
